XML 27 R16.htm IDEA: XBRL DOCUMENT v3.23.1
Change in Accounting Method
3 Months Ended
Mar. 31, 2023
Change in Accounting Method [Abstract]  
Change in Accounting Method
9.  Change in Accounting Method

Effective April 1, 2022, TransAct changed its method of inventory valuation from standard costing which approximates FIFO to the average costing methodology.  We believe this methodology is preferable because it reflects a better estimate of inventory cost as we do not typically perform intensive manufacturing of our finished products, which are therefore better measured under average cost.  Comparative financial statements of prior periods have been adjusted to apply the new method retrospectively.  Tax effects are calculated at the Company’s marginal tax rate, or the tax impact of incremental income changes rather than the average tax rate applied to our total net loss before income taxes.  The following financial statement line items for the periods presented were impacted by the change in accounting principle (dollars in thousands).

The effect of the changes made to the Company’s Condensed Consolidated Statements of Operations for the periods presented are as follows:

   
Three months ended March 31, 2022
 
 
Under
FIFO Cost
   
Under
Average Cost
   
Effect
of Change
 
Cost of sales
 
$
6,708
   
$
7,136
   
$
428
 
Gross profit
   
2,994
     
2,566
     
(428
)
Operating loss
   
(5,176
)
   
(5,604
)
   
(428
)
Loss before income taxes
   
(5,275
)
   
(5,703
)
   
(428
)
Income tax benefit
   
1,262
     
1,355
     
93
 
Net loss
   
(4,013
)
   
(4,348
)
   
(335
)
                         
Net loss per common share:
                       
Basic
 
$
(0.41
)
 
$
(0.44
)
 
$
(0.03
)
Diluted
 
$
(0.41
)
 
$
(0.44
)
 
$
(0.03
)
                         
Shares used in per-share calculation:
                       
Basic
   
9,886
     
9,886
         
Diluted
   
9,886
     
9,886
         

The effect of the changes made to the Company’s Condensed Consolidated Statements of Comprehensive Income (Loss) for the periods presented are as follows:

   
Three months ended March 31, 2022
 
   
Under
FIFO Cost
   
Under
Average Cost
   
Effect
of Change
 
Net loss
 
$
(4,013
)
 
$
(4,348
)
 
$
(335
)
Comprehensive loss
   
(4,055
)
   
(4,390
)
   
(335
)

The effect of the changes made to the Company’s Condensed Consolidated Statements of Cash Flows for the periods presented are as follows:

   
Three months ended March 31, 2022
 
 
Under
FIFO Cost
   
Under
Average Cost
   
Effect
of Change
 
Net loss
 
$
(4,013
)
 
$
(4,348
)
 
$
(335
)
Deferred income taxes
   
(1,262
)
   
(1,355
)
   
(93
)
Inventories
   
(1,344
)
   
(916
)
   
428
 

The effect of the changes made to the Company’s Condensed Consolidated Statements of Changes in Shareholders’ Equity for the periods presented are as follows:

   
Three months ended March 31, 2022
 
 
Under
FIFO Cost
   
Under
Average Cost
   
Effect
of Change
 
Equity beginning balance
 
$
38,991
   
$
38,984
   
$
(7
)
Retained earnings -- beginning of period
   
15,573
     
15,566
     
(7
)
Net loss
   
(4,013
)
   
(4,348
)
   
(335
)
Retained earnings -- end of period
   
11,560
     
11,218
     
(342
)
Equity ending balance
   
35,113
     
34,771
     
(342
)